Product Description

The theoretical basis of FBDD is to ｓelect favorable fragment combinations or extensions to obtain new drug molecules, with a higher probability of obtaining highly active drug candidates. Compared with the screening of millions of macromolecules, thousands of fragment molecules can be combined to form millions of drug structures, which are easier to collect ａnd manage. In addition, fragments have smaller molecular weights, relatively higher solubility, ａnd easier structural optimization. The potential of over-the-counter medicine is higher. The FragLites identify productive drug-like interactions, which are identified sensitively ａnd unambiguously by X-ray crystallography, exploiting the anomalous scattering of the halogen substituent. This mapping of protein interaction surfaces provides an assessment of druggability ａnd can identify efficient start points for the de novo design of hit molecules incorporating the interacting motifs.

Combine fragments from FragLites to generate fragment lead compounds:

化合物库定制

品牌介绍：
TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化域科学家的研究提供业的产品和服务。TargetMol品牌的客户群分布于40多个国家和地区，已发展成为全球大的化合物库和小分子化合物研究供应商。

原创作者：上海陶术生物科技有限公司